Literature DB >> 2409171

The contribution of neurogenic inflammation in experimental arthritis.

J D Levine, M A Moskowitz, A I Basbaum.   

Abstract

The release of the peptide neurotransmitter substance P from the peripheral terminals of nociceptive afferent neurons and the release of catecholamines from postganglionic sympathetic efferent neurons produce physiologic changes associated with acute inflammation. The contribution of these neurogenic mechanisms to inflammatory diseases has not been determined. Activation of central neural circuits elicits similar physiologic changes, and lesions of the peripheral and central nervous system are associated with alteration in activity of inflammatory diseases. We have evaluated the contribution of neurogenic inflammation to the severity of joint injury in experimentally induced arthritis in the rat. The finding of a greater density of substance P-containing nociceptive afferents in a joint that develops more severe arthritis (ankle) suggests a role of substance P in joint injury. Direct evidence that the proinflammatory factor released from these nociceptors is substance P is provided by the finding that the injection of substance P into a joint which normally develops less severe arthritis (knee) increases the severity of arthritis in that joint. A contribution of catecholamines to the severity of joint injury was suggested by the finding that both guanethidine-induced sympathectomy and reserpine-induced depletion of catecholamines attenuated the severity of joint injury. Finally, a contribution of central neural circuits to inflammatory processes was studied in a model in which activation of nociceptive afferents elicited swelling and tenderness at a remote site. This reflex neurogenic inflammation was inhibited by intracerebroventricular injections of morphine, which also attenuated the severity of arthritis. These studies provide evidence that elements of the peripheral afferent and sympathetic efferent neurons and of descending supraspinal, opioid-mediated, circuits in the central nervous system modulate the severity of joint injury in experimental arthritis in the rat.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409171

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Purinergic regulation of bradykinin-induced plasma extravasation and adjuvant-induced arthritis in the rat.

Authors:  P G Green; A I Basbaum; C Helms; J D Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Modifications of serotonin-, substance P- and calcitonin gene-related peptide-like immunoreactivities in the dorsal horn of the spinal cord of arthritic rats: a quantitative immunocytochemical study.

Authors:  L Marlier; P Poulat; N Rajaofetra; A Privat
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

3.  Medical sleuthing without an MRI.

Authors:  Alan Russell
Journal:  Can Fam Physician       Date:  2007-07       Impact factor: 3.275

4.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

Review 5.  Interstitial cystitis: the painful bladder syndrome.

Authors:  R Doggweiler-Wiygul; J Blankenship; S A MacDiarmid
Journal:  Curr Rev Pain       Date:  2000

6.  The role of joint nerves and mast cells in the alteration of vasoactive intestinal peptide (VIP) sensitivity during inflammation progression in rats.

Authors:  Jason J McDougall; Ali Kursat Barin
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 7.  Neuropeptides, inflammation, and motility.

Authors:  E A Mayer; H Raybould; C Koelbel
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

8.  TRPV1-Targeted Drugs in Development for Human Pain Conditions.

Authors:  Mircea Iftinca; Manon Defaye; Christophe Altier
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

9.  Excitatory amino acid profiles of synovial fluid from patients with arthritis.

Authors:  T McNearney; D Speegle; N Lawand; J Lisse; K N Westlund
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

Review 10.  Translational pain research: achievements and challenges.

Authors:  Jianren Mao
Journal:  J Pain       Date:  2009-07-22       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.